Estée Lauder
Up to $5,000
Claims opening soon
A Canada-wide settlement agreement has been reached concerning Depo-Provera, an injectable birth control, and its alleged link to bone mineral density loss.
Allegations that Pfizer misrepresented the risks of Depo-Provera, leading to bone mineral density loss.
A Canada-wide settlement agreement has been reached in a class action lawsuit alleging that Pfizer misrepresented the risks associated with Depo-Provera, an injectable birth control, by failing to disclose potential significant and possibly irreversible bone mineral density loss leading to osteopenia or osteoporosis. The proposed settlement applies to individuals in Canada who claim to have suffered bone mineral density loss due to Depo-Provera use before May 31, 2010. The settlement provides for a payment of $1,913,750.00 to the class and $262,500.00 to provincial health insurers. Class members who qualify will receive compensation for osteopenia, osteoporosis, and fragility fractures if the court approves the settlement. The approval hearing is scheduled for October 26, 2021. Objections to the settlement or legal fees must be submitted in writing by October 16, 2021. Class members can...
Closed settlement
Claim status: Closed on March 1, 2022
Estée Lauder
Up to $5,000
Claims opening soon
Audible
Compensation pending
Claims opening soon
Government of Canada
Up to $200,000
614 days left

Meta (Facebook)
Up to $90
Claims opening soon
Ticketmaster
Compensation pending
Claims opening soon
Apple
Up to $100
Claims opening soon